Status:
COMPLETED
High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial
Lead Sponsor:
University of the Punjab
Collaborating Sponsors:
The National HIV/AIDS Programme
Conditions:
HIV-1-infection
Hypovitaminosis D
Eligibility:
All Genders
19+ years
Phase:
PHASE3
Brief Summary
High-Dose Vitamin D3 in the Treatment of Human Immune Deficiency Virus Patients, A Double-Blind Randomized Control Trial Human immunodeficiency virus is a key challenge for global health. Vitamin D de...
Detailed Description
The study is designed to evaluate the effect of high dose Vitamin-D supplementation in the treatment of HIV patients with Antiretroviral therapy. Furthermore, in secondary outcomes study will evaluat...
Eligibility Criteria
Inclusion
- Age from 19 years and above
- Vitamin-D levels less than 20ng/ml
- Not taking any kind of Vitamin-D supplementation or Mega Doses for last six months
- Written Informed Consent Form
- PCR Positive Patients
Exclusion
- Pregnant and Lactating Women
- Ability to take Study Medication Orally
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT05306704
Start Date
February 15 2019
End Date
January 31 2022
Last Update
April 11 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Govt Said Mitha Teaching Hospital Lahore
Lahore, Punjab/ lahore/Pakistan, Pakistan, 5200
2
Fatima Majeed
Lahore, Punjab/ lahore/Pakistan, Pakistan, LAHORE